Literature DB >> 5549196

The effect of 2,3-DPG on the sickling phenomenon.

E Beutler, N V Paniker, C West.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5549196

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

2.  FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice.

Authors:  Archana Shrestha; Mengna Chi; Kimberly Wagner; Astha Malik; Jennifer Korpik; Adam Drake; Keertik Fulzele; Sylvie Guichard; Punam Malik
Journal:  Blood Adv       Date:  2021-05-11

Review 3.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

4.  Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.

Authors:  M Seakins; W N Gibbs; P F Milner; J F Bertles
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

Review 5.  New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Authors:  Esther Oder; Martin K Safo; Osheiza Abdulmalik; Gregory J Kato
Journal:  Br J Haematol       Date:  2016-09-08       Impact factor: 6.998

6.  Hematological and Genetic Predictors of Daytime Hemoglobin Saturation in Tanzanian Children with and without Sickle Cell Anemia.

Authors:  Sharon E Cox; Julie Makani; Charles R Newton; Andrew M Prentice; Fenella J Kirkham
Journal:  ISRN Hematol       Date:  2013-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.